Brief: Eliem Therapeutics Reports Fourth Quarter And Year-End Financial Results

Climb Bio

06/03/2023 23:44

March 6 (Reuters) - Eliem Therapeutics Inc  ELYM.O :
    * ELIEM THERAPEUTICS REPORTS FOURTH QUARTER AND YEAR-END
FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
    * ELIEM THERAPEUTICS INC - IMPLEMENTED CORPORATE
REORGANIZATION
AND PIPELINE REPRIORITIZATION EXTENDING CASH RUNWAY INTO 2027
    * ELIEM THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES WERE $123.6 MILLION AS OF DECEMBER 31, 2022
    * ELIEM THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.29

Source text for Eikon:  ID:nGNX1mRVTz 
Further company coverage:  ELYM.O